EMAIL THIS PAGE TO A FRIEND

Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Clinical experience with cyclooxygenase-2 inhibitors.


PMID 10391112

Abstract

Increasing amounts of experimental and clinical data support the role of selective cyclooxygenase (COX)-2 inhibition in anti-inflammatory processes and the role of COX-1 inhibition in increasing the frequency of side effects. This article reviews the regulation of COX-2 in inflammatory processes based on in vitro and in vivo work. In addition, it summarizes the various in vitro assays used to classify the new generation of selective and highly selective inhibitors of COX-2, since prior categorization of NSAIDs does not satisfactorily encompass the COX-2 concept. Finally, the latest published clinical data of new selective and highly selective inhibitors of COX-2 (meloxicam, nimesulide, etodolac, celecoxib and MK966) are discussed.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

N1016
Nimesulide
C13H12N2O5S